
ALHC Earnings
Alignment Healthcare Inc
- Overview
- Forecast
- Valuation
- Earnings
Earning Analysis
Welcome to our in-depth analysis of Alignment Healthcare Inc(ALHC) earnings, offering investors a detailed look into the company’s financial performance, revenue trends, earnings per share (EPS), and market reactions. This page provides a comprehensive overview of Alignment Healthcare Inc earnings history, forecasts, and key financial metrics, empowering you with the data needed to make informed investment decisions. Whether you're tracking quarterly results, analyzing earnings surprises, or exploring future projections, our detailed breakdown covers it all.
Earnings Forecast
Revenue
EPS
Currency: USD
Actual
Estimate
Surprise Analysis
FY2025Q2 | 2025-07-30 | After Hours | -0.07 | 0.07 | +200.00 | 960.51M | 1.02B | +5.70 | +6.00 | +3.15 |
FY2025Q1 | 2025-05-01 | After Hours | -0.05 | -0.05 | - | 888.26M | 926.93M | +4.35 | -7.39 | -7.45 |
FY2024Q4 | 2025-02-27 | After Hours | -0.18 | -0.16 | +11.11 | 677.42M | 701.24M | +3.52 | +16.48 | +13.21 |
FY2024Q3 | 2024-10-29 | After Hours | -0.14 | -0.14 | - | 662.32M | 692.43M | +4.55 | +0.17 | +13.41 |
FY2024Q2 | 2024-08-01 | - | -0.14 | -0.13 | +7.14 | 637.65M | 681.29M | +6.84 | -1.37 | +0.11 |
FY2024Q1 | 2024-05-02 | - | -0.24 | -0.25 | -4.17 | 597.74M | 628.60M | +5.16 | +0.77 | +29.89 |
FY2023Q4 | 2024-02-27 | - | -0.22 | -0.25 | -13.64 | 444.60M | 465.39M | +4.67 | +11.43 | -13.04 |
FY2023Q2 | 2023-08-03 | - | -0.21 | -0.15 | +28.57 | 438.56M | 462.38M | +5.43 | -3.67 | +10.67 |
- | 2023-05-04 | - | -0.25 | -0.20 | +20.00 | - | - | - | +5.11 | +5.11 |
- | 2023-02-28 | - | -0.30 | -0.31 | -3.33 | - | - | - | +3.43 | -24.97 |
ALHC Earnings Analysis
Our earnings analysis provides a granular look at the company’s performance across recent fiscal quarters, highlighting key metrics such as revenue, EPS, and operating margins. By examining actual results against analyst estimates, we uncover trends and surprises that drive stock price movements, offering valuable insights for both short-term traders and long-term investors.
In the most recent quarter, Alignment Healthcare Inc reported performance for FY2025Q2, announced on 2025-07-30. The company achieved an EPS of 0.07, compared to analyst estimates of -0.07 by 200.00% . Revenue for the quarter reached 1.02B compared to expectations of 960.51M by 5.70% .
The stock price reacted with a 6.00% one-day change and a 3.15% five-day change following the earnings release. These movements reflect market reaction in Alignment Healthcare Inc growth trajectory and strategic initiatives.
ALHC Earnings Forecast
Looking ahead, Alignment Healthcare Inc(ALHC) remains a focal point for investors seeking growth opportunities. Analyst forecasts for 2025/Q3 project quarter revenue of 978.27M and an EPS of 0.00.
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2025 have been Revise Upward by 0.19%, while EPS estimates have been No Change by 0%. For the upcoming Q3 2025, revenue estimates have been adjusted Revise Upward by 2.37% . These revisions correlate with a -0.74% change in stock price over the same period, suggesting potential buying opportunities for investors who believe in Alignment Healthcare Inc long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.
Estimate Revision
The chart shows the correlation between ALHC's stock price and earnings forecast revisions. Positive revisions in Revenue or EPS often strengthen the stock's fundamentals, making price dips potential buying opportunities.
Revenue Estimates for FY2025
Revise Upward

+0.19%
In Past 3 Month
EPS Estimates for FY2025
No Change

0.00%
In Past 3 Month
Revenue Estimates for Q3 2025
Revise Upward

+2.37%
In Past 3 Month
Stock Price
Go Down

-0.74%
In Past 3 Month
1Y
3Y
5Y
Annual FY 2025
Currency: USD
1Y
3Y
5Y
--
Revenue Estimate-Annual FY 2025:3.80B
--
EPS Estimate-Annual FY 2025:0.01
—
Stock Price14.80
ALHC Revenue and EPS Performance: A Historical Perspective
Alignment Healthcare Inc revenue and earnings per share (EPS) performance over recent quarters provides a clear picture of its financial health. Below is a detailed breakdown of the company’s earnings history, showcasing actual results, analyst estimates, and surprise percentages for key fiscal quarters:
FY2025Q2 (2025-07-30,After Hours):
EPS: 0.07 (Actual) vs.-0.07 (Estimate) (200.00%)
Revenue: 1.02B (Actual) vs. 960.51M (Estimate) (5.70%)
Price Reaction: 6.00%(1-Day), 3.15%(5-Day)
FY2025Q1 (2025-05-01,After Hours):
EPS: -0.05 (Actual) vs.-0.05 (Estimate) (0.00%)
Revenue: 926.93M (Actual) vs. 888.26M (Estimate) (4.35%)
Price Reaction: -7.39%(1-Day), -7.45%(5-Day)
FY2024Q4 (2025-02-27,After Hours):
EPS: -0.16 (Actual) vs.-0.18 (Estimate) (11.11%)
Revenue: 701.24M (Actual) vs. 677.42M (Estimate) (3.52%)
Price Reaction: 16.48%(1-Day), 13.21%(5-Day)
Earnings Reaction
The chart below shows how ALHC performed 10 days before and after its earnings report, based on data from the past quarters. Typically, ALHC sees a +1.75% change in stock price 10 days leading up to the earnings, and a -0.12% change 10 days following the report. On the earnings day itself, the stock moves by +2.45%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in JUN/2025, the stock changed 6.00% on the day following the earnings release and then changed by 13.54% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
Transcript Summary
Alignment Healthcare Inc (ALHC) Q2 2025 Earnings Call Summary
Positive
2025-07-31
The earnings call summary reflects strong financial performance with significant revenue and profit growth, alongside improved operational efficiency. Market strategy and product development updates are promising, with a focus on technology and market expansion. The Q&A insights reveal stable utilization trends, efficient SG&A management, and positive member engagement, all contributing to a positive outlook. Despite management's reluctance to provide specific marketing details, the overall sentiment is positive due to robust guidance and strategic investments, indicating potential stock price growth of 2% to 8%.
Alignment Healthcare Inc (ALHC) Q1 2025 Earnings Call Summary
Positive
2025-05-02
The company demonstrated strong financial performance with significant revenue growth and adjusted EBITDA margin expansion. Despite competitive pressures and some regulatory challenges, the company is less impacted by regulatory changes compared to competitors. The guidance for 2025 is optimistic with raised revenue and adjusted EBITDA outlooks. Analysts showed positive sentiment, particularly about the company's competitive position and financial stability. Although there are risks, the overall sentiment and guidance suggest a positive stock price movement in the short term for this small-cap company.
Alignment Healthcare Inc (ALHC) Q4 2024 Earnings Call Summary
Positive
2025-03-03
The earnings call highlights robust financial performance, including record revenue and positive adjusted EBITDA, marking the company's first year of profitability. Membership growth is strong, with a significant increase in both California and non-California markets. The guidance for 2025 is optimistic with a focus on profitability and cost control. Although there are some uncertainties in the Q&A, the overall sentiment is positive, supported by strong financial metrics and strategic growth plans. Given the market cap of $1.5 billion, the stock is likely to see a positive reaction, potentially in the 2% to 8% range.
Alignment Healthcare Inc (ALHC) Q4 2024 Earnings Call Summary
Positive
2025-02-28
The company demonstrated strong financial performance with record revenue growth, improved margins, and achieved positive adjusted EBITDA for the first time as a public company. The Q&A section showed management's confidence in future growth, despite some uncertainties regarding the Part D program and MLR guidance. The absence of a share repurchase program is a slight negative, but overall, the financial health and optimistic guidance suggest a positive stock price movement. Considering the company's small-cap status, a positive sentiment is likely to result in a 2% to 8% increase in stock price.
Alignment Healthcare, Inc. (ALHC) Q3 2024 Earnings Call Summary
Positive
2024-10-30
The earnings call highlights strong financial performance with record high revenue and positive adjusted EBITDA. Membership growth and raised guidance for 2024 are positive indicators. Despite some risks like regulatory changes and competitive pressures, the company has a clear strategy for growth and improvement. The Q&A session revealed analysts' positive sentiment towards the company's innovation and strategic investments. The lack of a shareholder return plan is a minor negative, but overall, the positive financial metrics and guidance outweigh the concerns, leading to a positive stock price prediction.
Alignment Healthcare, Inc. (ALHC) Q2 2024 Earnings Call Summary
Positive
2024-08-04
The earnings call highlights strong financial performance with revenue and membership growth surpassing expectations. Despite regulatory and market challenges, management's optimistic outlook for margin expansion and strategic focus on profitability and partnerships is promising. The positive adjusted EBITDA and improved MBR further boost confidence. Although there are concerns about expenses and competition, the overall sentiment remains positive due to strong growth metrics and optimistic guidance for 2025. The market cap suggests a moderate reaction, leading to a prediction of a 2% to 8% stock price increase over the next two weeks.
People Also Watch

LCII
LCI Industries
104.650
USD
-0.59%

NOMD
Nomad Foods Ltd
14.990
USD
-2.66%

NSA
National Storage Affiliates Trust
30.140
USD
-0.59%

OSIS
OSI Systems Inc
234.450
USD
-0.68%

AAP
Advance Auto Parts Inc
57.160
USD
-7.52%

PRK
Park National Corp
168.890
USD
-1.08%

PAR
PAR Technology Corp
51.940
USD
+1.43%

HUBG
Hub Group Inc
36.010
USD
-1.93%

MAN
ManpowerGroup Inc
41.045
USD
-1.74%
FAQ

What were the key highlights of ALHC’s latest earnings report for FY2025Q2?
ALHC reported its FY2025Q2 earnings on 2025-07-30, showcasing a revenue of 1.02B against an estimate of 960.51M, resulting in a 5.7% surprise. The EPS was 0.07, surpassing the expected -0.07 by 200% . The stock experienced a 6% price change on the earnings day and a 3.15% change over the next five days, reflecting market reactions to the results.

How did ALHC’s stock price react after the FY2025Q2 earnings release?

What are the revenue and EPS estimates for ALHC for 2025/Q3?

How does ALHC’s stock price correlate with earnings forecast revisions?

What should investors expect from ALHC’s next earnings report?
